Some experts, however, expressed concerns about the platform and raised questions about Lillys financial motives
There are several GLP-1 agonist drugs available
Yes, individuals with a history of gallbladder disease, rapid weight loss, obesity, and those consuming a diet high in fats and low in fiber may be at an increased risk of developing gallbladder problems while on semaglutide
From our list of the top 5 diabetes drugs in 2025, its evident that the introduction of more effective GLP-1 receptor agonists , SGLT2 inhibitors , and once-weekly insulin is on track to significantly advance diabetes care
With this drug, you have the potential not just to keep someone from developing type 2 diabetes, but reducing risk for prediabetes, Fujioka told Endocrine Today